These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12352803)

  • 1. Consequences of delayed measles vaccination in Germany.
    Siedler A; Hermann M; Schmitt HJ; Von Kries R
    Pediatr Infect Dis J; 2002 Sep; 21(9):826-30. PubMed ID: 12352803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward measles elimination in Germany.
    Hellenbrand W; Siedler A; Tischer A; Meyer C; Reiter S; Rasch G; Teichmann D; Santibanez S; Altmann D; Claus H; Kramer M
    J Infect Dis; 2003 May; 187 Suppl 1():S208-16. PubMed ID: 12721915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months.
    Cutts FT; Othepa O; Vernon AA; Nyandu B; Markowitz LE; Deforest A; Wilkins K; Okwo B
    Int J Epidemiol; 1994 Jun; 23(3):624-31. PubMed ID: 7960392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of measles vaccine effectiveness, Australia, 2006-2012.
    Pillsbury A; Quinn H
    Western Pac Surveill Response J; 2015; 6(3):43-50. PubMed ID: 26668766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.
    De Serres G; Boulianne N; Defay F; Brousseau N; Benoît M; Lacoursière S; Guillemette F; Soto J; Ouakki M; Ward BJ; Skowronski DM
    Clin Infect Dis; 2012 Aug; 55(3):394-402. PubMed ID: 22543023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles immunization: early two-doses policy experience.
    al-Mazrou YY; al-Jeffri M; Ahmed OM; Aziz KM; Mishkas AH
    J Trop Pediatr; 1999 Apr; 45(2):98-104. PubMed ID: 10341504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closer to the goal: efforts in measles elimination in Germany 2010.
    Siedler A; Mankertz A; Feil F; Ahlemeyer G; Hornig A; Kirchner M; Beyrer K; Dreesman J; Scharkus S; Marcic A; Reiter S; Matysiak-Klose D; Santibanez S; Krause G; Wichmann O
    J Infect Dis; 2011 Jul; 204 Suppl 1():S373-80. PubMed ID: 21666187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles vaccine effectiveness in standard and early immunization strategies, Niger, 1995.
    Kaninda AV; Legros D; Jataou IM; Malfait P; Maisonneuve M; Paquet C; Moren A
    Pediatr Infect Dis J; 1998 Nov; 17(11):1034-9. PubMed ID: 9849988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China.
    Hu Y; Chen Y; Wang Y; Liang H
    Hum Vaccin Immunother; 2018 Apr; 14(4):875-880. PubMed ID: 29252094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles vaccination coverage, determinants of delayed vaccination and reasons for non-vaccination among children aged 24-35 months in Zhejiang province, China.
    Hu Y; Wang Y; Chen Y; Liang H; Chen Z
    BMC Public Health; 2018 Nov; 18(1):1298. PubMed ID: 30482185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating age-specific vaccine effectiveness using data from a large measles outbreak in Berlin, Germany, 2014/15: evidence for waning immunity.
    Bitzegeio J; Majowicz S; Matysiak-Klose D; Sagebiel D; Werber D
    Euro Surveill; 2019 Apr; 24(17):. PubMed ID: 31039834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of mass measles campaigns among children less than 5 years old in Uganda.
    Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
    J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed measles vaccination of toddlers in Canada: Associated socio-demographic factors and parental knowledge, attitudes and beliefs.
    Périnet S; Kiely M; De Serres G; Gilbert NL
    Hum Vaccin Immunother; 2018 Apr; 14(4):868-874. PubMed ID: 29211621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of measles immunization and effective population vaccine coverage.
    Bielicki JA; Achermann R; Berger C
    Pediatrics; 2012 Sep; 130(3):e600-6. PubMed ID: 22908102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules.
    van den Hof S; Wallinga J; Widdowson MA; Conyn-van Spaendonck MA
    Epidemiol Infect; 2002 Feb; 128(1):47-57. PubMed ID: 11895090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surveillance of measles in Germany].
    Tischer A; Siedler A; Rasch G
    Gesundheitswesen; 2001 Nov; 63(11):703-9. PubMed ID: 11713702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.